摘要:
A fluorine-containing copolymer, containing: chlorotrifluoroethylene monomer units (A); and monomer units (B), which are obtained by polymerizing a monomer selected from the group consisting of (i) a monomer having a formula: CH2═CHCOON(R0)2, wherein each R0 is independently a hydrogen or an alkyl group; (ii) N-vinylcaprolactam; (iii) a monomer having a formula: CH2═CR1CH2OCH2CR2═CH2, wherein R1 and R2 are each independently a hydrogen, a fluorine, or a methyl group; (iv) a monomer having a formula: CH2═CHCH2CH(CH3)—R3, wherein R3 is a linear alkyl group comprising 1 to 7 carbons; and (v) a monomer of methyl 2-fluoroacrylate, wherein a ratio, (A)/((A)+(B)), is from 3 to 99 mol %, a fluorine content of the copolymer is from 15 to 75 mol %, and a molecular weight of the copolymer is from 1,000 to 1,000,000.
摘要:
Quinolin-2-yl benzoic acid compounds which are useful as intermediates of quinoline compounds having angiotensin II antagonist activity prepared by decarboxylating 2-(carboxyphenyl)-4-quinolinecarboxylic acid compounds in which a carboxyl group bonded to a phenyl group may be esterified, while a carboxyl group bonded to a quinoline ring is not esterified, and both rings may have one or more substituents inert to the decarboxylation reaction.
摘要:
A quinoline compound represented by the formula (1) or a salt thereof: ##STR1## wherein the definition of each substituents are described in the specification, which have angiotensin II antagonism and hypotensive action and are useful as an agent for the prevention and treatment of cardiovascular system diseases such as hypertension, heart failure and the like.
摘要:
A quinoline compound represented by the formula (1) or a salt thereof: ##STR1## wherein the definition of each substituents are described in the specification, which have angiotensin II antagonism and hypotensive action and are useful as an agent for the prevention and treatment of cardiovascular system diseases such as hypertension, heart failure and the like.
摘要:
2-Arylquinolines represented by formula (1): ##STR1## wherein R.sup.1, R.sup.3 to R.sup.9 each represents hydrogen, halogen, lower alkyl, cyclic lower alkyl, aryl, aralkyl, alkoxy or --C.sub.m F.sub.2m+1 ; R.sup.2 represents hydrogen, halogen, lower alkyl, cyclic lower alkyl, aryl, aralkyl, alkoxy, --C.sub.n F.sub.2n+1 or --CH.sub.2 Q, in which Q represents a monovalent organic group obtained by eliminating from an organic compound having --NH-- the hydrogen atom bonded to the nitrogen, or halogen; X represents halogen or hydrogen; Y represents nitro or amino which may be protected with a protecting group; and m and n each represents an integer of from 1 to 6; and processes for producing the 2-arylquinolines.
摘要翻译:由式(1)表示的2-芳基喹啉:其中R 1,R 3至R 9各自表示氢,卤素,低级烷基,环状低级烷基,芳基,芳烷基,烷氧基或-C m F 2 m + 1; R2表示氢,卤素,低级烷基,环状低级烷基,芳基,芳烷基,烷氧基,-CnF2n + 1或-CH2Q,其中Q表示通过从具有-NH-的有机化合物中除去氢原子键合获得的一价有机基团 氮或卤素; X表示卤素或氢; Y表示可被保护基保护的硝基或氨基; m和n各自表示1〜6的整数, 以及2-芳基喹啉的制造方法。
摘要:
An isoindazole compound of the formula (1) or a salt thereof; a method for the production thereof; and pharmaceutical use of the compound and a salt thereof, particularly as an angiotensin II antagonist and as an agent for the prophylaxis and treatment of circulatory diseases (particularly hypertension and heart failure); ##STR1## wherein Q is a heterocyclic derivative of the formula (2) or (3) ##STR2## wherein other symbols of the above formulas are as defined in the Specification. The compound and its salt show superior angiotensin II antagonism and are low toxic. Accordingly, they are useful as angiotensin II antagonists for the treatment or prophylaxis of angiotensin II-mediated diseases such as circulatory diseases of hypertension (e.g. essential hypertension, renal hypertension) and heart failure.
摘要:
To provide a composition comprising a fluorocopolymer such as an ethylene/tetrafluoroethylene copolymer which can be produced at a relatively low temperature, and its production process.A fluorocopolymer composition which comprises a fluorocopolymer such as an ethylene/tetrafluoroethylene copolymer and a fluorinated aromatic compound having a melting point of at most 230° C. and having a fluorine content in the compound of from 5 to 75 mass %, and is in a solution state at a temperature of at most the melting point of the fluorocopolymer, and a process for producing the fluorocopolymer composition, which comprises a step of dissolving the fluorocopolymer in a solvent containing the fluorinated aromatic compound at a temperature of at most the melting point of the fluorocopolymer.
摘要:
To provide a lecithinized superoxide dismutase (PC-SOD) composition useful as a drug material and a process for its production. The PC-SOD composition contains a PC-SOD obtained by substituting at least amino group in a specific SOD with a lecithin moiety represented by the following formula (I), wherein the PC-SOD contains a PC-SOD (A) having an m number of amino groups substituted with the lecithin moieties (wherein m is an integer of from 1 to 4 and averages from 1.5 to 2.4 as a main component and the PC-SOD (A) consists of a PC-SOD (a1) wherein m=1, a PC-SOD (a2) wherein m=2, a PC-SOD (a3) wherein m=3 and a PC-SOD (a4) wherein m=4.
摘要:
To provide a composition comprising a fluorocopolymer such as an ETFE which can be produced at a relatively low temperature, and its production process.A fluorocopolymer composition which comprises a fluorocopolymer such as an ETFE and a C6-10 aliphatic compound having one carbonyl group, and which is in a solution state being at a temperature of at most the melting point of the fluorocopolymer, and a process for producing the fluorocopolymer composition, which comprises a step of dissolving the fluorocopolymer in the aliphatic compound having one carbonyl group at a temperature of at most the melting point of the fluorocopolymer.
摘要:
To provide a method for easily producing an ethylene/tetrafluoroethylene copolymer porous material having excellent chemical resistance and filtration performance and has a high heat resistance, within a wide range of the porosity, and an ethylene/tetrafluoroethylene copolymer porous material obtained by such a process.A process for producing an ethylene/tetrafluoroethylene copolymer porous material which comprises a step of dissolving an ethylene/tetrafluoroethylene copolymer having repeating units based on ethylene and repeating units based on tetrafluoroethylene at a temperature of at most 300° C. in a solvent which can dissolve the ethylene/tetrafluoroethylene copolymer at a temperature of at most 300° C., to achieve a predetermined concentration to obtain a solution, a step of forming the solution to obtain a formed product, and a step of cooling the formed product to a temperature of at most the phase separation temperature of the solution to solidify the ethylene/tetrafluoroethylene copolymer.